These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
358 related items for PubMed ID: 11115442
1. Additive effects of salmeterol and fluticasone or theophylline in COPD. Cazzola M, Di Lorenzo G, Di Perna F, Calderaro F, Testi R, Centanni S. Chest; 2000 Dec; 118(6):1576-81. PubMed ID: 11115442 [Abstract] [Full Text] [Related]
4. Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. Pearlman DS, Stricker W, Weinstein S, Gross G, Chervinsky P, Woodring A, Prillaman B, Shah T. Ann Allergy Asthma Immunol; 1999 Mar; 82(3):257-65. PubMed ID: 10094216 [Abstract] [Full Text] [Related]
5. Salmeterol & fluticasone 50 microg/250 microg bid in combination provides a better long-term control than salmeterol 50 microg bid alone and placebo in COPD patients already treated with theophylline. Dal Negro RW, Pomari C, Tognella S, Micheletto C. Pulm Pharmacol Ther; 2003 Mar; 16(4):241-6. PubMed ID: 12850128 [Abstract] [Full Text] [Related]
8. Comparison of a combination of tiotropium plus formoterol to salmeterol plus fluticasone in moderate COPD. Rabe KF, Timmer W, Sagkriotis A, Viel K. Chest; 2008 Aug; 134(2):255-262. PubMed ID: 18403672 [Abstract] [Full Text] [Related]
10. Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Markham A, Jarvis B. Drugs; 2000 Nov; 60(5):1207-33. PubMed ID: 11129128 [Abstract] [Full Text] [Related]
12. The efficacy and safety of combination salmeterol (50 microg)/fluticasone propionate (500 microg) inhalation twice daily via accuhaler in Chinese patients with COPD. Zheng JP, Yang L, Wu YM, Chen P, Wen ZG, Huang WJ, Shi Y, Wang CZ, Huang SG, Sun TY, Wang GF, Xiong SD, Zhong NS. Chest; 2007 Dec; 132(6):1756-63. PubMed ID: 17951625 [Abstract] [Full Text] [Related]
18. Efficacy, tolerability, and effects on quality of life of inhaled salmeterol and oral theophylline in patients with mild-to-moderate chronic obstructive pulmonary disease. SLMT02 Italian Study Group. Di Lorenzo G, Morici G, Drago A, Pellitteri ME, Mansueto P, Melluso M, Norrito F, Squassante L, Fasolo A. Clin Ther; 1998 Dec; 20(6):1130-48. PubMed ID: 9916607 [Abstract] [Full Text] [Related]
19. Effect of fluticasone with and without salmeterol on pulmonary outcomes in chronic obstructive pulmonary disease: a randomized trial. Lapperre TS, Snoeck-Stroband JB, Gosman MM, Jansen DF, van Schadewijk A, Thiadens HA, Vonk JM, Boezen HM, Ten Hacken NH, Sont JK, Rabe KF, Kerstjens HA, Hiemstra PS, Timens W, Postma DS, Sterk PJ, Groningen Leiden Universities Corticosteroids in Obstructive Lung Disease Study Group. Ann Intern Med; 2009 Oct 20; 151(8):517-27. PubMed ID: 19841453 [Abstract] [Full Text] [Related]
20. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease. Vestbo J, Pauwels R, Anderson JA, Jones P, Calverley P, TRISTSAN study group. Thorax; 2005 Apr 20; 60(4):301-4. PubMed ID: 15790985 [Abstract] [Full Text] [Related] Page: [Next] [New Search]